N/RX Trademark

Trademark Overview

On Thursday, December 10, 2009, a trademark application was filed for N/RX with the United States Patent and Trademark Office. The USPTO has given the N/RX trademark a serial number of 77890744. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by BIO-VED Pharmaceuticals, Inc.. The N/RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
n/rx

General Information

Serial Number77890744
Word MarkN/RX
Filing DateThursday, December 10, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number3958943
Registration DateTuesday, May 10, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2010

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateTuesday, February 2, 2010
First Use In Commerce DateTuesday, February 2, 2010

Trademark Owner History

Party NameBIO-VED Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131
Party NameBIO-VED Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131
Party NameBIO-VED Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95131

Trademark Events

Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, May 10, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 17, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, June 17, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, June 17, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 2, 2016TEAS SECTION 8 RECEIVED
Tuesday, May 10, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 10, 2011REGISTERED-PRINCIPAL REGISTER
Saturday, April 2, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, April 1, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 1, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 17, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 15, 2011USE AMENDMENT FILED
Tuesday, March 15, 2011TEAS STATEMENT OF USE RECEIVED
Friday, March 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2011EXTENSION 1 GRANTED
Wednesday, December 29, 2010EXTENSION 1 FILED
Wednesday, March 9, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 16, 2011EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, February 16, 2011PETITION TO REVIVE-GRANTED
Wednesday, February 16, 2011TEAS PETITION TO REVIVE RECEIVED
Monday, January 31, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 31, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 29, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 4, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 31, 2010ASSIGNED TO LIE
Tuesday, March 16, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 12, 2010ASSIGNED TO EXAMINER
Tuesday, December 15, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

development research pharmaceutical